AKT1 and pancreatic ductal adenocarcinoma: On the contrary, Wang et al. showed that LncRNA ab209630 enhanced the sensitivity of pancreatic ductal adenocarcinoma to gemcitabine by inhibiting the PI3K/AKT signaling pathway 30.